Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.

[1]  Wei-Chun Chang,et al.  Low-Dose, Prophylactic, Extended-Field, Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin for Patients With Stage IB2-IIIB Cervical Cancer, Positive Pelvic Lymph Nodes, and Negative Para-aortic Lymph Nodes , 2014, International Journal of Gynecologic Cancer.

[2]  E. Miyagi,et al.  Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer. , 2013, Gynecologic oncology.

[3]  S. Beriwal,et al.  Are Radiation Therapy Oncology Group Para-aortic Contouring Guidelines for Pancreatic Neoplasm applicable to other malignancies--assessment of nodal distribution in gynecological malignancies. , 2013, International journal of radiation oncology, biology, physics.

[4]  C. Haie-meder,et al.  Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Ho-Chun Song,et al.  Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography. , 2012, International journal of radiation oncology, biology, physics.

[6]  T. Nakano,et al.  Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer , 2012, Journal of radiation research.

[7]  C. Haie-meder,et al.  Nodal-staging surgery for locally advanced cervical cancer in the era of PET. , 2012, The Lancet. Oncology.

[8]  B. Erickson,et al.  Extended-Field Irradiation and Intracavitary Brachytherapy Combined With Cisplatin and Amifostine for Cervical Cancer With Positive Para-Aortic or High Common Iliac Lymph Nodes: Results of Arm II of Radiation Therapy Oncology Group (RTOG) 0116 , 2011, International Journal of Gynecologic Cancer.

[9]  L. Ramondetta,et al.  Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. , 2011, Cancer.

[10]  L. Ramondetta,et al.  Laparoscopic extraperitoneal para‐aortic lymphadenectomy in locally advanced cervical cancer 1 , 2011 .

[11]  A. Dueñas-González,et al.  Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Grigsby,et al.  Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  K. Chao,et al.  Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy. , 2010, American journal of obstetrics and gynecology.

[14]  T. Yen,et al.  A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy. , 2010, International journal of radiation oncology, biology, physics.

[15]  P. Grigsby,et al.  Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. , 2008, International journal of radiation oncology, biology, physics.

[16]  P. Rose,et al.  Surgical versus radiographic determination of para‐aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma , 2008, Cancer.

[17]  Javier Zamora,et al.  Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis , 2008, Canadian Medical Association Journal.

[18]  B. Erickson,et al.  Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. , 2007, International journal of radiation oncology, biology, physics.

[19]  D. Heron,et al.  Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. , 2007, International Journal of Radiation Oncology, Biology, Physics.

[20]  Christian Kirisits,et al.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Silvia D. Chang,et al.  Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. , 2004, International journal of radiation oncology, biology, physics.

[22]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  K. Ng,et al.  Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. , 2003, Gynecologic oncology.

[24]  G. Thomas,et al.  Is there a role for pelvic lymph node debulking in advanced cervical cancer? , 2002, Gynecologic oncology.

[25]  L. Twiggs,et al.  Pretreatment surgical staging of patients with cervical carcinoma , 1998, Cancer.

[26]  P. Grigsby,et al.  Prophylactic Extended-Field Irradiation of Para-aortic Lymph Nodes in Stages IIB and Bulky IB and IIA Cervical Carcinomas: Ten-Year Treatment Results of RTOG 79-20 , 1995 .

[27]  J. Fowler.  The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[28]  A. Gerbaulet,et al.  Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[30]  J. Dimopoulos,et al.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  Sasa Mutic,et al.  PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. , 2003, International journal of radiation oncology, biology, physics.

[32]  P. Grigsby,et al.  Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. , 2001, International journal of radiation oncology, biology, physics.